Skip to main navigation Skip to search Skip to main content

Clinical outcomes of 188 patients implanted with Med-El stapes prostheses

  • Wendelin Wolfram
  • , Paul Martin Zwittag
  • , Lisa Niederwanger
  • , Nina Rubicz
  • , Georg Sprinzl
  • , Astrid Magele
  • , Dirk Beutner
  • , Nicholas Bevis
  • , Esther Schimanski
  • , Susan Arndt
  • , Christian Offergeld
  • , Christoph Arnoldner
  • , Dominik Riss
  • , Piotr H Skarżyński
  • , Łukasz Plichta
  • , Joachim Hornung
  • , Lava Taha
  • , Thomas Lenarz
  • , Susan Busch
  • , Franz Windisch
  • Benjamin Loader
  • Department of Otorhinolaryngology
  • Kepler University Hospital GmbH
  • University Clinic St. Pölten
  • University of Göttingen
  • Zentrum Fuer Mittelohrchirurgie (Centre for Middle Ear Surgery)
  • University of Freiburg Medical Center
  • Medical University of Vienna
  • Center of Hearing and Speech MEDINCUS
  • University of Erlangen-Nuremberg
  • Hannover Medical School
  • Head and Neck Surgery
  • Klinik Landstrasse
  • Vienna Health Care Group

Research output: Contribution to journalArticlepeer-review

Abstract

PURPOSE: This multicentric, retrospective study aimed to analyze the safety and effectiveness of the mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, and mFIX Stapes Prosthesis.

METHODS: Patients underwent stapes surgery and implantation of a mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, or mFIX Stapes Prosthesis (MED-EL, Innsbruck, Austria). The clinical data was retrospectively analyzed. Follow-up examination included access to medical records (for adverse events) of the patients, ear microscopy and pure-tone audiometry to determine the post-operative pure tone average of the frequencies 0.5, 1, 2 and 3 kHz (PTA4). The post-operative PTA4 air bone gap (ABG) was used to evaluate the audiological outcome. A post-operative PTA4 ABG ≤ 20 dB was defined as successful rehabilitation. A post-operative minimum and maximum follow-up period was not defined.

RESULTS: 189 patients were implanted with a MED-EL stapes prosthesis mainly as treatment of hearing loss caused by otosclerosis. 188 (186 adults, 2 children; 57 conductive hearing loss (CHL), 131 mixed hearing loss (MHL)) patients were examined for adverse events (AEs). 168 (166 adults, 2 children, 51 CHL, 117 MHL) patients underwent audiological examination. Audiology: 110 (65.5%) patients achieved a post-operative PTA4 ABG ≤ 10 dB. 154 (91.7%) patients achieved a post-operative PTA4 ABG ≤ 20 dB and therefore successful rehabilitation. Individual bone conduction (BC) PTA4 thresholds were stable in 159 (94.6%) patients. AEs: 12 (6.4%, adults only) patients had 13 AEs.

CONCLUSION: Clinical data demonstrated satisfactory audiological results after implantation of the mAXIS Stapes Prosthesis, mLOOP Stapes Prosthesis, mZAM Stapes Prosthesis, and mFIX Stapes Prosthesis. The MED-EL stapes prostheses are safe and effective.

TRIAL REGISTRATION NUMBER: NCT05565339 (clinicaltrials.gov).

Original languageEnglish
Pages (from-to)781-790
Number of pages10
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume283
Issue number2
DOIs
Publication statusPublished - Feb 2026

Keywords

  • Humans
  • Female
  • Male
  • Retrospective Studies
  • Ossicular Prosthesis
  • Middle Aged
  • Adult
  • Stapes Surgery/methods
  • Treatment Outcome
  • Otosclerosis/surgery
  • Audiometry, Pure-Tone
  • Hearing Loss, Conductive/surgery
  • Aged
  • Prosthesis Design
  • Young Adult
  • Adolescent
  • Child
  • Bone Conduction
  • Follow-Up Studies

Fingerprint

Dive into the research topics of 'Clinical outcomes of 188 patients implanted with Med-El stapes prostheses'. Together they form a unique fingerprint.

Cite this